Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Avalo Therapeutics Inc. sell Lokrim

Avalo Therapeutics Inc.
Start price
€9.52
04.08.24 / 20%
Target price
-
04.08.25
Performance (%)
-40.65%
End price
€5.65
21.07.25
Summary
This prediction ended on 21.07.25 with a price of €5.65. Lokrim correctly predicted massive losses of -40.65% for Avalo Therapeutics Inc.. Lokrim has a follow-up prediction for Avalo Therapeutics Inc., but this time predicts that Avalo Therapeutics Inc. is a Buy. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Avalo Therapeutics Inc. - - -
iShares Core DAX® 1.917% 1.088% 17.187%
iShares Nasdaq 100 0.911% 1.674% 7.930%
iShares Nikkei 225® 0.833% -1.712% 12.100%
iShares S&P 500 0.242% 1.258% 3.167%

According to Lokrim what are the pros and cons of Avalo Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Revenue decline/stagnation expected

Comments by Lokrim for this prediction

In the thread Avalo Therapeutics Inc. diskutieren

Sell Avalo Therapeutics Inc.

Lokrim 
0
Report Share
04.08.24 Sell -40.65%
In the thread Trading Avalo Therapeutics Inc.
Prediction Sell
Perf. (%) -40.65%
Target price
Change
Ends at 04.08.25

Sell beendet

Lokrim 
0
Report Share
21.07.25

Current prediction by Lokrim for Avalo Therapeutics Inc.

buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.65
21.07.25
-
21.07.26
199.82%
08.12.25

Could be worthwhile Investment >10% per year
Capable Management
Revenue decline/stagnation expected
Lokrim 
21.07.25 20%